Healing
TB-500
Longevity
7
Amino acids
Molecular weight
Peptide
Type
A synthetic 7-amino acid fragment corresponding to the actin-binding region of thymosin beta-4, originally developed for equine use with retained tissue repair properties. TB-500 acts as principal actin-sequestering protein, regulating cell migration, promoting angiogenesis, reducing inflammation, and activating stem cell differentiation.
Acts as principal actin-sequestering protein, regulating cell migration, promoting angiogenesis, reducing inflammation, and activating stem cell differentiation for comprehensive regenerative effects.
Reconstituted: 2-8°C, use within 28 days
2-3x weekly (e.g., Monday, Wednesday, Friday)
2-5mg per injection (higher doses for serious injuries)
6-8 weeks for active healing
Superior systemic tissue repair
Accelerated muscle, tendon, and ligament healing
Enhanced cell migration and angiogenesis
Comprehensive regenerative effects
Neuroprotective properties
This peptide is still gaining traction in the community.
Synthetic Fragment (17-23) of Thymosin Beta-4
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of TB-500.
7
Amino Acids
TB-500
Leu
Leu
Position 1
Lys
Lys
Position 2
Lys
Lys
Position 3
Thr
Thr
Position 4
Glu
Glu
Position 5
Thr
Thr
Position 6
Gln
Gln
Position 7
Subcutaneous or intramuscular injection. Flexible timing with no empty stomach requirement. Can be injected near injury site for localized effect.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| General tissue repair | 2 | 2 week range | SubQ or IM |
| Serious injury recovery | 4 | 3 week range | SubQ near injury site |
| Athletic enhancement | 2 | 2 week range | SubQ |
| Chronic conditions | 3 | 2 week range | SubQ or IM |
| Maintenance | 2 | 1 week range | SubQ |
| Post-surgical recovery | 3 | 3 week range | SubQ |
Materials needed:
Steps to reconstitute
The TB-500 Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
Safe concentration range
TB-500
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg TB-500 vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Research suggestions of TB-500 interactions with other common peptides and substances.
Healing
bpc
Longevity
SYNERGISTIC
Complementary healing mechanisms with enhanced tissue repair when combined (Wolverine Stack).
Weight
ipa
Growth
COMPATIBLE
May enhance tissue sensitivity to growth hormone effects.
Active cancer treatment (due to angiogenic effects)
Pregnancy or breastfeeding
Immunosuppressive medications (consult provider)
WADA prohibited for competitive athletes
Persistent or worsening injection site infections
Unusual swelling or prolonged redness
Severe allergic reactions
Unexpected systemic symptoms
Concerning health changes
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
TB-500 is a well studied compound
TB-500
TB-500 is a well studied compound
Dermal Wound Healing Study
Significant acceleration in wound healing rates in patients with chronic pressure ulcers and venous stasis ulcers compared to placebo in Phase 2 human trial.
2012
Cardiac Tissue Regeneration
TB-500 pre-treated endothelial cells improved left ventricular function by greater than 50% in post-MI subjects in human clinical trial.
2016
Muscle Fiber Regeneration
Improved skeletal muscle fiber regeneration in dystrophin-deficient mice, showing potential for muscular dystrophy treatment.
2015
Corneal Healing Research
Topical TB-500 significantly improved signs and symptoms of moderate to severe dry eye with lasting effects in Phase 2 human trial.
2014